RxSight, Inc. (RXST) Q2 FY26 Earnings Call

Alcon funding and strategic validation contrast with declining core volumes and withdrawn 2026 guidance.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-05
Length34 minutes
EPS$-0.29
EPS consensus$-0.37
Revenue$30.9M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

All RXST earnings ยท Back to RXST overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.